Home › Companies › Avadel Pharmaceuticals plc › 2025-2026
Compiled from SEC Form N-PX filings and Avadel Pharmaceuticals plc’s Form 8-K, filed January 12, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of January 12, 2026: 4 items on Avadel Pharmaceuticals plc’s Form 8-K, filed January 12, 2026: 3 approved · 1 without a stated outcome.
Meeting of July 29, 2025: 8 items on Avadel Pharmaceuticals plc’s Form 8-K, filed July 29, 2025: 1 approved · 7 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore Avadel Pharmaceuticals plc in the interactive database Compare manager voting policies
These tallies are Avadel Pharmaceuticals plc’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed January 12, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. Avadel Pharmaceuticals plc reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. To approve the Scheme | 61,861,352 | 1,646,857 | 160,443 | -- | -- | 97% | Not verified | — |
| 1. To approve the Scheme | 62,444,065 | 2,247,706 | 167,662 | -- | -- | 97% | Approved | — |
| 2. To amend the Articles of Association of Avadel so that any ordinary shares of Avadel that are issued on or after the voting record time to persons other than Alkermes or its nominee(s) will either be subject to the Scheme or will be immediately and automati | 61,808,690 | 2,673,461 | 377,282 | -- | -- | 96% | Approved | — |
| 3. To approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Acquisition | 55,489,041 | 8,757,025 | 613,367 | -- | -- | 86% | Approved | — |
Source: Avadel Pharmaceuticals plc, Form 8-K, filed with the SEC on January 12, 2026 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Gregory J. Divis | 55,893,759 | 11,003,833 | -- | 73,447 | 16,688,424 | 84% | Not verified | — |
| Elect Director: Dr. Eric J. Ende | 54,662,863 | 12,179,679 | -- | 128,497 | 16,688,424 | 82% | Not verified | — |
| Elect Director: Geoffrey M. Glass | 55,513,034 | 11,294,176 | -- | 163,829 | 16,688,424 | 83% | Not verified | — |
| Elect Director: Dr. Mark A. McCamish | 54,941,279 | 11,975,126 | -- | 54,634 | 16,688,424 | 82% | Not verified | — |
| Elect Director: Linda S. Palczuk | 55,634,574 | 11,150,992 | -- | 185,473 | 16,688,424 | 83% | Not verified | — |
| Elect Director: Peter J. Thornton | 54,875,660 | 12,038,935 | -- | 56,444 | 16,688,424 | 82% | Not verified | — |
| Elect Director: Dr. Naseem S. Amin | 54,468,817 | 12,317,559 | -- | 184,663 | 16,688,424 | 82% | Not verified | — |
| 2. To ratify, on a non-binding advisory basis, the appointment of Deloitte & Touche LLP as the Company's independent registered public auditor and accounting firm for the fiscal year ending December 31, 2025, and to authorize, in a binding vote, the Audit Comm | 78,493,206 | 4,621,257 | 545,000 | -- | 0 | 94% | Approved | — |
Source: Avadel Pharmaceuticals plc, Form 8-K, filed with the SEC on July 29, 2025 — read the filing on EDGAR.
Each item below shows how the 229 asset managers that disclosed a Avadel Pharmaceuticals plc vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Avadel Pharmaceuticals plc’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held July 29, 2025.
Combines 3 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Dr. Eric J. Ende
Avadel Pharmaceuticals plc’s own tally for this item (“Elect Director: Dr. Eric J. Ende”): 54,662,863 for, 12,179,679 against, per its Form 8-K filed July 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 14,719,678 for, 232,854 against, 61,400 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 3,934,141 | 0 | 0 | 0 | For |
| Vanguard | 3,846,121 | 0 | 0 | 0 | For |
| BlackRock | 2,686,017 | 0 | 0 | 0 | For |
| Fidelity | 1,377,260 | 0 | 0 | 0 | For |
| Datum One Series Trust | 1,284,943 | 0 | 0 | 0 | For |
| DWS | 439,453 | 0 | 0 | 0 | For |
| Charles Schwab | 229,851 | 0 | 0 | 0 | For |
| Equitable | 151,095 | 0 | 61,400 | 0 | Mixed |
| TIAA | 0 | 198,136 | 0 | 0 | Against |
| Morgan Stanley | 104,917 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,700 | 0 | 0 | 0 | For |
| Global X | 55,466 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 52,691 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 50,567 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,735 | 0 | 0 | 0 | For |
| Northern Trust | 42,538 | 0 | 0 | 0 | For |
| State Street | 39,818 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 37,433 | 0 | 0 | 0 | For |
| Royce | 35,460 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 35,008 | 0 | 0 | 0 | For |
| JPMorgan | 33,496 | 0 | 0 | 0 | For |
| John Hancock | 31,432 | 0 | 0 | 0 | For |
| Pacific Life | 28,355 | 0 | 0 | 0 | For |
| ProShares | 20,838 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,092 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Meeting held July 29, 2025.
Combines 4 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Dr. Mark A. McCamish
Avadel Pharmaceuticals plc’s own tally for this item (“Elect Director: Dr. Mark A. McCamish”): 54,941,279 for, 11,975,126 against, per its Form 8-K filed July 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 15,013,551 for, 381 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 3,934,141 | 0 | 0 | 0 | For |
| Vanguard | 3,846,121 | 0 | 0 | 0 | For |
| BlackRock | 2,686,017 | 0 | 0 | 0 | For |
| Fidelity | 1,377,260 | 0 | 0 | 0 | For |
| Datum One Series Trust | 1,284,943 | 0 | 0 | 0 | For |
| DWS | 439,453 | 0 | 0 | 0 | For |
| Charles Schwab | 229,851 | 0 | 0 | 0 | For |
| Equitable | 212,495 | 0 | 0 | 0 | For |
| TIAA | 198,136 | 0 | 0 | 0 | For |
| Morgan Stanley | 104,917 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,700 | 0 | 0 | 0 | For |
| Global X | 55,466 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 52,691 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 50,567 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,735 | 0 | 0 | 0 | For |
| Northern Trust | 42,538 | 0 | 0 | 0 | For |
| State Street | 39,818 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 37,433 | 0 | 0 | 0 | For |
| Royce | 35,460 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 35,008 | 0 | 0 | 0 | For |
| JPMorgan | 33,496 | 0 | 0 | 0 | For |
| John Hancock | 31,432 | 0 | 0 | 0 | For |
| Pacific Life | 28,355 | 0 | 0 | 0 | For |
| ProShares | 20,838 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,092 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Meeting held July 29, 2025.
Combines 3 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Dr. Naseem S. Amin
Avadel Pharmaceuticals plc’s own tally for this item (“Elect Director: Dr. Naseem S. Amin”): 54,468,817 for, 12,317,559 against, per its Form 8-K filed July 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 14,737,060 for, 215,472 against, 61,400 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 3,934,141 | 0 | 0 | 0 | For |
| Vanguard | 3,846,121 | 0 | 0 | 0 | For |
| BlackRock | 2,686,017 | 0 | 0 | 0 | For |
| Fidelity | 1,377,260 | 0 | 0 | 0 | For |
| Datum One Series Trust | 1,284,943 | 0 | 0 | 0 | For |
| DWS | 439,453 | 0 | 0 | 0 | For |
| Charles Schwab | 229,851 | 0 | 0 | 0 | For |
| Equitable | 151,095 | 0 | 61,400 | 0 | Mixed |
| TIAA | 0 | 198,136 | 0 | 0 | Against |
| Morgan Stanley | 104,917 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,700 | 0 | 0 | 0 | For |
| Global X | 55,466 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 52,691 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 50,567 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,735 | 0 | 0 | 0 | For |
| Northern Trust | 42,538 | 0 | 0 | 0 | For |
| State Street | 39,818 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 37,433 | 0 | 0 | 0 | For |
| Royce | 35,460 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 35,008 | 0 | 0 | 0 | For |
| JPMorgan | 33,496 | 0 | 0 | 0 | For |
| John Hancock | 31,432 | 0 | 0 | 0 | For |
| Pacific Life | 28,355 | 0 | 0 | 0 | For |
| ProShares | 20,838 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,092 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Meeting held July 29, 2025.
Combines 2 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Geoffrey M. Glass
Avadel Pharmaceuticals plc’s own tally for this item (“Elect Director: Geoffrey M. Glass”): 55,513,034 for, 11,294,176 against, per its Form 8-K filed July 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 14,737,441 for, 215,091 against, 61,400 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 3,934,141 | 0 | 0 | 0 | For |
| Vanguard | 3,846,121 | 0 | 0 | 0 | For |
| BlackRock | 2,686,017 | 0 | 0 | 0 | For |
| Fidelity | 1,377,260 | 0 | 0 | 0 | For |
| Datum One Series Trust | 1,284,943 | 0 | 0 | 0 | For |
| DWS | 439,453 | 0 | 0 | 0 | For |
| Charles Schwab | 229,851 | 0 | 0 | 0 | For |
| Equitable | 151,095 | 0 | 61,400 | 0 | Mixed |
| TIAA | 0 | 198,136 | 0 | 0 | Against |
| Morgan Stanley | 104,917 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,700 | 0 | 0 | 0 | For |
| Global X | 55,466 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 52,691 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 50,567 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,735 | 0 | 0 | 0 | For |
| Northern Trust | 42,538 | 0 | 0 | 0 | For |
| State Street | 39,818 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 37,433 | 0 | 0 | 0 | For |
| Royce | 35,460 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 35,008 | 0 | 0 | 0 | For |
| JPMorgan | 33,496 | 0 | 0 | 0 | For |
| John Hancock | 31,432 | 0 | 0 | 0 | For |
| Pacific Life | 28,355 | 0 | 0 | 0 | For |
| ProShares | 20,838 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,092 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Meeting held July 29, 2025.
Combines 2 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Gregory J. Divis
Avadel Pharmaceuticals plc’s own tally for this item (“Elect Director: Gregory J. Divis”): 55,893,759 for, 11,003,833 against, per its Form 8-K filed July 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 15,013,932 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 3,934,141 | 0 | 0 | 0 | For |
| Vanguard | 3,846,121 | 0 | 0 | 0 | For |
| BlackRock | 2,686,017 | 0 | 0 | 0 | For |
| Fidelity | 1,377,260 | 0 | 0 | 0 | For |
| Datum One Series Trust | 1,284,943 | 0 | 0 | 0 | For |
| DWS | 439,453 | 0 | 0 | 0 | For |
| Charles Schwab | 229,851 | 0 | 0 | 0 | For |
| Equitable | 212,495 | 0 | 0 | 0 | For |
| TIAA | 198,136 | 0 | 0 | 0 | For |
| Morgan Stanley | 104,917 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,700 | 0 | 0 | 0 | For |
| Global X | 55,466 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 52,691 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 50,567 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,735 | 0 | 0 | 0 | For |
| Northern Trust | 42,538 | 0 | 0 | 0 | For |
| State Street | 39,818 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 37,433 | 0 | 0 | 0 | For |
| Royce | 35,460 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 35,008 | 0 | 0 | 0 | For |
| JPMorgan | 33,496 | 0 | 0 | 0 | For |
| John Hancock | 31,432 | 0 | 0 | 0 | For |
| Pacific Life | 28,355 | 0 | 0 | 0 | For |
| ProShares | 20,838 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,092 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Meeting held July 29, 2025.
Combines 2 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Linda S. Palczuk
Avadel Pharmaceuticals plc’s own tally for this item (“Elect Director: Linda S. Palczuk”): 55,634,574 for, 11,150,992 against, per its Form 8-K filed July 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 14,737,060 for, 215,472 against, 61,400 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 3,934,141 | 0 | 0 | 0 | For |
| Vanguard | 3,846,121 | 0 | 0 | 0 | For |
| BlackRock | 2,686,017 | 0 | 0 | 0 | For |
| Fidelity | 1,377,260 | 0 | 0 | 0 | For |
| Datum One Series Trust | 1,284,943 | 0 | 0 | 0 | For |
| DWS | 439,453 | 0 | 0 | 0 | For |
| Charles Schwab | 229,851 | 0 | 0 | 0 | For |
| Equitable | 151,095 | 0 | 61,400 | 0 | Mixed |
| TIAA | 0 | 198,136 | 0 | 0 | Against |
| Morgan Stanley | 104,917 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,700 | 0 | 0 | 0 | For |
| Global X | 55,466 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 52,691 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 50,567 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,735 | 0 | 0 | 0 | For |
| Northern Trust | 42,538 | 0 | 0 | 0 | For |
| State Street | 39,818 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 37,433 | 0 | 0 | 0 | For |
| Royce | 35,460 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 35,008 | 0 | 0 | 0 | For |
| JPMorgan | 33,496 | 0 | 0 | 0 | For |
| John Hancock | 31,432 | 0 | 0 | 0 | For |
| Pacific Life | 28,355 | 0 | 0 | 0 | For |
| ProShares | 20,838 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,092 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Meeting held July 29, 2025.
Combines 2 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Peter J. Thornton
Avadel Pharmaceuticals plc’s own tally for this item (“Elect Director: Peter J. Thornton”): 54,875,660 for, 12,038,935 against, per its Form 8-K filed July 29, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 15,013,551 for, 381 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 3,934,141 | 0 | 0 | 0 | For |
| Vanguard | 3,846,121 | 0 | 0 | 0 | For |
| BlackRock | 2,686,017 | 0 | 0 | 0 | For |
| Fidelity | 1,377,260 | 0 | 0 | 0 | For |
| Datum One Series Trust | 1,284,943 | 0 | 0 | 0 | For |
| DWS | 439,453 | 0 | 0 | 0 | For |
| Charles Schwab | 229,851 | 0 | 0 | 0 | For |
| Equitable | 212,495 | 0 | 0 | 0 | For |
| TIAA | 198,136 | 0 | 0 | 0 | For |
| Morgan Stanley | 104,917 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,700 | 0 | 0 | 0 | For |
| Global X | 55,466 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 52,691 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 50,567 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,735 | 0 | 0 | 0 | For |
| Northern Trust | 42,538 | 0 | 0 | 0 | For |
| State Street | 39,818 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 37,433 | 0 | 0 | 0 | For |
| Royce | 35,460 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 35,008 | 0 | 0 | 0 | For |
| JPMorgan | 33,496 | 0 | 0 | 0 | For |
| John Hancock | 31,432 | 0 | 0 | 0 | For |
| Pacific Life | 28,355 | 0 | 0 | 0 | For |
| ProShares | 20,838 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,092 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Meeting held January 12, 2026.
100% of fund votes cast · no official result
Description as filed by funds: SPECIAL RESOLUTION TO APPROVE AN AMENDMENT TO THE ARTICLES OF ASSOCIATION OF AVADEL SO THAT ANY AVADEL SHARES THAT ARE ISSUED ON OR AFTER THE VOTING RECORD TIME TO PERSONS OTHER THAN ALKERMES PLC OR ITS NOMINEE(S) WILL EITHER BE SUBJECT TO THE SCHEME OR WILL BE IMMEDIATELY AND AUTOMATICALLY ACQUIRED BY ALKERMES PLC AND/OR ITS NOMINEE(S) FOR THE SCHEME CONSIDERATION.
The 55 asset managers below reported 17,718,324 for, 66,610 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,759,295 | 0 | 0 | 0 | For |
| BlackRock | 3,385,680 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,964,523 | 0 | 0 | 0 | For |
| Fidelity | 1,939,632 | 0 | 0 | 0 | For |
| Charles Schwab | 792,811 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 722,701 | 0 | 0 | 0 | For |
| Datum One Series Trust | 594,902 | 0 | 0 | 0 | For |
| DWS | 582,442 | 0 | 0 | 0 | For |
| TIAA | 499,377 | 0 | 0 | 0 | For |
| First Trust | 490,491 | 0 | 0 | 0 | For |
| Invesco | 362,363 | 0 | 0 | 0 | For |
| State Street | 256,813 | 0 | 0 | 0 | For |
| Equitable | 137,635 | 0 | 62,800 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 152,718 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 150,863 | 0 | 0 | 0 | For |
| Lincoln Financial | 112,884 | 0 | 0 | 0 | For |
| Goldman Sachs | 97,661 | 0 | 0 | 0 | For |
| Northern Trust | 56,843 | 0 | 0 | 0 | For |
| Morningstar Funds Trust | 55,604 | 0 | 0 | 0 | For |
| AQR | 49,231 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 46,881 | 0 | 0 | 0 | For |
| Brighthouse | 42,183 | 0 | 3,810 | 0 | Mixed |
| Voya | 45,827 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,645 | 0 | 0 | 0 | For |
| Global X | 42,916 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Meeting held January 12, 2026.
Combines 3 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: Ordinary resolution to approve the Scheme and authorize the directors of Avadel Pharmaceuticals plc ("Avadel") to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect.
The 54 asset managers below reported 17,721,713 for, 62,800 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,759,295 | 0 | 0 | 0 | For |
| BlackRock | 3,385,680 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,964,523 | 0 | 0 | 0 | For |
| Fidelity | 1,939,632 | 0 | 0 | 0 | For |
| Charles Schwab | 792,811 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 722,701 | 0 | 0 | 0 | For |
| Datum One Series Trust | 594,902 | 0 | 0 | 0 | For |
| DWS | 582,442 | 0 | 0 | 0 | For |
| TIAA | 499,377 | 0 | 0 | 0 | For |
| First Trust | 490,491 | 0 | 0 | 0 | For |
| Invesco | 362,363 | 0 | 0 | 0 | For |
| State Street | 256,813 | 0 | 0 | 0 | For |
| Equitable | 137,635 | 0 | 62,800 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 152,718 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 150,863 | 0 | 0 | 0 | For |
| Lincoln Financial | 112,884 | 0 | 0 | 0 | For |
| Goldman Sachs | 97,661 | 0 | 0 | 0 | For |
| Northern Trust | 56,843 | 0 | 0 | 0 | For |
| Morningstar Funds Trust | 55,604 | 0 | 0 | 0 | For |
| AQR | 49,231 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 46,881 | 0 | 0 | 0 | For |
| Brighthouse | 45,993 | 0 | 0 | 0 | For |
| Voya | 45,827 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,645 | 0 | 0 | 0 | For |
| Global X | 42,916 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Meeting held January 12, 2026.
100% of fund votes cast · no official result
Description as filed by funds: THAT THE SCHEME IN ITS ORIGINAL FORM OR WITH OR SUBJECT TO ANY MODIFICATION(S), ADDITION(S) OR CONDITION(S) APPROVED OR IMPOSED BY THE IRISH HIGH COURT BE AGREED TO.
The 35 asset managers below reported 11,838,795 for, 62,800 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,759,295 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,964,523 | 0 | 0 | 0 | For |
| Fidelity | 1,939,632 | 0 | 0 | 0 | For |
| DWS | 582,442 | 0 | 0 | 0 | For |
| TIAA | 499,377 | 0 | 0 | 0 | For |
| First Trust | 490,491 | 0 | 0 | 0 | For |
| Invesco | 362,363 | 0 | 0 | 0 | For |
| State Street | 256,813 | 0 | 0 | 0 | For |
| Equitable | 137,635 | 0 | 62,800 | 0 | Mixed |
| Janus Detroit Street Trust | 150,863 | 0 | 0 | 0 | For |
| Lincoln Financial | 112,884 | 0 | 0 | 0 | For |
| Goldman Sachs | 90,435 | 0 | 0 | 0 | For |
| Northern Trust | 56,843 | 0 | 0 | 0 | For |
| AQR | 49,231 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 46,881 | 0 | 0 | 0 | For |
| Voya | 45,827 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,645 | 0 | 0 | 0 | For |
| Brighthouse | 42,183 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 37,693 | 0 | 0 | 0 | For |
| ProShares | 34,520 | 0 | 0 | 0 | For |
| Pacific Life | 26,854 | 0 | 0 | 0 | For |
| Nationwide | 25,163 | 0 | 0 | 0 | For |
| Virtus | 16,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 12,349 | 0 | 0 | 0 | For |
| T. Rowe Price | 9,224 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Meeting held January 12, 2026.
100% of fund votes cast · no official result
The 2 asset managers below reported 492,726 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 417,044 | 0 | 0 | 0 | For |
| Lincoln Financial | 75,682 | 0 | 0 | 0 | For |
Meeting held January 12, 2026.
96% Approved · of votes cast
Description as filed by funds: Amend Articles of Association
Avadel Pharmaceuticals plc’s own tally for this item (“2. To amend the Articles of Association of Avadel so that any ordinary shares of Avadel that are issued on or after the voting record time to persons other than Alkermes or its nominee(s) will either be subject to the Sc”): 61,808,690 for, 2,673,461 against — passed, per its Form 8-K filed January 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Avadel shareholders approved the proposal with the following voting results:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 2 asset managers below reported 246,363 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 208,522 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,841 | 0 | 0 | 0 | For |
Meeting held January 12, 2026.
98% of fund votes cast · no official result
Description as filed by funds: ORDINARY RESOLUTION TO APPROVE ANY MOTION BY THE CHAIR TO ADJOURN THE EXTRAORDINARY GENERAL MEETING, OR ANY ADJOURNMENTS THEREOF, TO ANOTHER TIME AND PLACE IF NECESSARY OR APPROPRIATE TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE EXTRAORDINARY GENERAL MEETING TO APPROVE RESOLUTIONS 1 AND 2.
The 55 asset managers below reported 17,383,677 for, 334,647 against, 66,610 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,759,295 | 0 | 0 | 0 | For |
| BlackRock | 3,385,680 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,964,523 | 0 | 0 | 0 | For |
| Fidelity | 1,939,632 | 0 | 0 | 0 | For |
| Charles Schwab | 792,811 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 722,701 | 0 | 0 | 0 | For |
| Datum One Series Trust | 594,902 | 0 | 0 | 0 | For |
| DWS | 582,442 | 0 | 0 | 0 | For |
| TIAA | 499,377 | 0 | 0 | 0 | For |
| First Trust | 490,491 | 0 | 0 | 0 | For |
| Invesco | 362,363 | 0 | 0 | 0 | For |
| State Street | 0 | 256,813 | 0 | 0 | Against |
| Equitable | 137,635 | 0 | 62,800 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 152,718 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 150,863 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,184 | 63,700 | 0 | 0 | Mixed |
| Goldman Sachs | 97,661 | 0 | 0 | 0 | For |
| Northern Trust | 56,843 | 0 | 0 | 0 | For |
| Morningstar Funds Trust | 55,604 | 0 | 0 | 0 | For |
| AQR | 49,231 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 44,381 | 2,500 | 0 | 0 | Mixed |
| Brighthouse | 42,183 | 0 | 3,810 | 0 | Mixed |
| Voya | 45,827 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,645 | 0 | 0 | 0 | For |
| Global X | 42,916 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Meeting held January 12, 2026.
97% of fund votes cast · no official result
Description as filed by funds: THAT, ANY MOTION BY THE CHAIR TO ADJOURN THE SCHEME MEETING, OR ANY ADJOURNMENTS THEREOF, TO ANOTHER TIME AND PLACE IF NECESSARY OR APPROPRIATE TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE SCHEME MEETING TO APPROVE THE SCHEME, BE APPROVED.
The 35 asset managers below reported 11,504,148 for, 334,647 against, 62,800 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,759,295 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,964,523 | 0 | 0 | 0 | For |
| Fidelity | 1,939,632 | 0 | 0 | 0 | For |
| DWS | 582,442 | 0 | 0 | 0 | For |
| TIAA | 499,377 | 0 | 0 | 0 | For |
| First Trust | 490,491 | 0 | 0 | 0 | For |
| Invesco | 362,363 | 0 | 0 | 0 | For |
| State Street | 0 | 256,813 | 0 | 0 | Against |
| Equitable | 137,635 | 0 | 62,800 | 0 | Mixed |
| Janus Detroit Street Trust | 150,863 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,184 | 63,700 | 0 | 0 | Mixed |
| Goldman Sachs | 90,435 | 0 | 0 | 0 | For |
| Northern Trust | 56,843 | 0 | 0 | 0 | For |
| AQR | 49,231 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 44,381 | 2,500 | 0 | 0 | Mixed |
| Voya | 45,827 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 43,645 | 0 | 0 | 0 | For |
| Brighthouse | 42,183 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 37,693 | 0 | 0 | 0 | For |
| ProShares | 34,520 | 0 | 0 | 0 | For |
| Pacific Life | 26,854 | 0 | 0 | 0 | For |
| Nationwide | 25,163 | 0 | 0 | 0 | For |
| Virtus | 16,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 12,349 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 9,224 | 0 | 0 | Against |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Meeting held January 12, 2026.
100% of fund votes cast · no official result
The 2 asset managers below reported 492,726 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 417,044 | 0 | 0 | 0 | For |
| Lincoln Financial | 75,682 | 0 | 0 | 0 | For |
Meeting held January 12, 2026.
Combines 6 wordings of this item as funds reported it.
86% Approved · of votes cast
Description as filed by funds: ORDINARY RESOLUTION TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, SPECIFIED COMPENSATORY ARRANGEMENTS BETWEEN AVADEL AND ITS NAMED EXECUTIVE OFFICERS RELATING TO THE TRANSACTION.
Avadel Pharmaceuticals plc’s own tally for this item (“3. To approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Acquisition”): 55,489,041 for, 8,757,025 against — passed, per its Form 8-K filed January 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Avadel shareholders approved the proposal with the following voting results:”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,759,295 | 0 | 0 | 0 | For |
| BlackRock | 3,385,680 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,964,523 | 0 | 0 | 0 | For |
| Fidelity | 1,939,632 | 0 | 0 | 0 | For |
| Charles Schwab | 792,811 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 722,701 | 0 | 0 | 0 | For |
| Datum One Series Trust | 0 | 594,902 | 0 | 0 | Against |
| DWS | 582,442 | 0 | 0 | 0 | For |
| TIAA | 0 | 499,377 | 0 | 0 | Against |
| First Trust | 490,491 | 0 | 0 | 0 | For |
| Invesco | 362,363 | 0 | 0 | 0 | For |
| State Street | 256,813 | 0 | 0 | 0 | For |
| Equitable | 137,635 | 62,800 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 152,718 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 150,863 | 0 | 0 | 0 | For |
| Lincoln Financial | 112,884 | 0 | 0 | 0 | For |
| Goldman Sachs | 97,661 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 56,843 | 0 | 0 | Against |
| Morningstar Funds Trust | 55,604 | 0 | 0 | 0 | For |
| AQR | 49,231 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 46,881 | 0 | 0 | 0 | For |
| Brighthouse | 42,183 | 0 | 3,810 | 0 | Mixed |
| Voya | 0 | 45,827 | 0 | 0 | Against |
| AIG/SunAmerica | 43,645 | 0 | 0 | 0 | For |
| Global X | 42,916 | 0 | 0 | 0 | For |
Fund voting reports, all 55 managers: 16,504,055 for, 1,277,069 against, 3,810 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 7,710,173 | 0 | 0 | 0 | For |
| BlackRock | 3,908,256 | 0 | 0 | 0 | For |
| Fidelity | 7,174 | 2,822,777 | 0 | 0 | Against |
| TIG Advisors, LLC | 2,745,251 | 0 | 0 | 0 | For |
| Vivo Capital, LLC | 2,684,109 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 2,398,853 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,193,961 | 0 | 0 | 0 | For |
| State Street | 2,089,088 | 2,901 | 0 | 0 | For |
| OAK RIDGE INVESTMENTS LLC | 1,684,000 | 0 | 0 | 0 | For |
| Pentwater Capital Management LP | 1,684,000 | 0 | 0 | 0 | For |
| TUDOR INVESTMENT CORP ET AL | 1,573,175 | 0 | 0 | 0 | For |
| Citadel | 1,393,576 | 0 | 0 | 0 | For |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 797,521 | 0 | 0 | 0 | For |
| BRANDES INVESTMENT PARTNERS, LP | 0 | 797,376 | 0 | 0 | Against |
| WATER ISLAND CAPITAL LLC | 796,712 | 0 | 0 | 0 | For |
| Charles Schwab | 792,956 | 0 | 0 | 0 | For |
| Vanguard | 763,434 | 0 | 0 | 0 | For |
| Northern Trust | 28,206 | 647,367 | 0 | 0 | Against |
| Neuberger Berman | 664,822 | 0 | 0 | 0 | For |
| Utah Retirement Systems | 603,790 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 523,473 | 0 | 0 | 0 | For |
| Nuveen | 0 | 514,901 | 0 | 0 | Against |
| Logos Global Management LP | 500,000 | 0 | 0 | 0 | For |
| Invesco | 417,927 | 0 | 0 | 0 | For |
| Wellington | 382,676 | 0 | 0 | 0 | For |
Institutional-manager reports, all 180 managers: 41,666,071 for, 5,249,825 against, 116,959 abstained. Showing the 25 largest; see all in the interactive database.
Meeting held January 12, 2026.
Combines 2 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 208,522 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,841 | 0 | 0 | 0 | For |
Fund voting reports, all 2 managers: 246,363 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WEXFORD CAPITAL LP | 150,000 | 0 | 0 | 0 | For |
| TD Waterhouse Canada Inc. | 1,242 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 151,242 for.
Meeting held July 29, 2025.
Combines 2 wordings of this item as funds reported it.
94% Approved · of votes cast
Description as filed by funds: TO RATIFY, ON A NON-BINDING ADVISORY BASIS, THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC AUDITOR AND ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025, AND TO AUTHORIZE, IN A BINDING VOTE, THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS TO SET THE INDEPENDENT REGISTERED PUBLIC AUDITOR AND ACCOUNTING FIRM REMUNERATION
Avadel Pharmaceuticals plc’s own tally for this item (“2. To ratify, on a non-binding advisory basis, the appointment of Deloitte & Touche LLP as the Company's independent registered public auditor and accounting firm for the fiscal year ending December 31, 2025, and to auth”): 78,493,206 for, 4,621,257 against — passed, per its Form 8-K filed July 29, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: To ratify, on a non-binding advisory basis, the appointment of Deloitte & Touche LLP as the Company's independent registered public auditor and accounting firm for the fiscal year ending December 31, 2025, and to authorize, in a binding vote, the Audit Committee of the Board to set the …”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 15,013,932 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 3,934,141 | 0 | 0 | 0 | For |
| Vanguard | 3,846,121 | 0 | 0 | 0 | For |
| BlackRock | 2,686,017 | 0 | 0 | 0 | For |
| Fidelity | 1,377,260 | 0 | 0 | 0 | For |
| Datum One Series Trust | 1,284,943 | 0 | 0 | 0 | For |
| DWS | 439,453 | 0 | 0 | 0 | For |
| Charles Schwab | 229,851 | 0 | 0 | 0 | For |
| Equitable | 212,495 | 0 | 0 | 0 | For |
| TIAA | 198,136 | 0 | 0 | 0 | For |
| Morgan Stanley | 104,917 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,700 | 0 | 0 | 0 | For |
| Global X | 55,466 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 52,691 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 50,567 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,735 | 0 | 0 | 0 | For |
| Northern Trust | 42,538 | 0 | 0 | 0 | For |
| State Street | 39,818 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 37,433 | 0 | 0 | 0 | For |
| Royce | 35,460 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 35,008 | 0 | 0 | 0 | For |
| JPMorgan | 33,496 | 0 | 0 | 0 | For |
| John Hancock | 31,432 | 0 | 0 | 0 | For |
| Pacific Life | 28,355 | 0 | 0 | 0 | For |
| ProShares | 20,838 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,092 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 97,235,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.89% |
| 2 | BlackRock | 3.48% |
| 3 | JANUS INVESTMENT FUND | 2.02% |
| 4 | Fidelity | 1.99% |
| 5 | Charles Schwab | 0.82% |
| 6 | ARBITRAGE FUNDS | 0.74% |
| 7 | Datum One Series Trust | 0.61% |
| 8 | DWS | 0.60% |
| 9 | TIAA | 0.51% |
| 10 | First Trust | 0.50% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 7.93% |
| 2 | BlackRock | 4.02% |
| 3 | Fidelity | 2.91% |
| 4 | TIG Advisors, LLC | 2.82% |
| 5 | Vivo Capital, LLC | 2.76% |
| 6 | BALYASNY ASSET MANAGEMENT L.P. | 2.47% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.26% |
| 8 | State Street | 2.15% |
| 9 | OAK RIDGE INVESTMENTS LLC | 1.73% |
| 10 | Pentwater Capital Management LP | 1.73% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 6.03% | 13F |
| Jeffrey L. Gendell | 4.98% | 13G |
| JANUS HENDERSON GROUP PLC | 1.88% | 13G |
| Morgan Stanley | 0.54% | 13F |
| BRANDES INVESTMENT PARTNERS, LP | 0.23% | 13G |
Percentages above are of 97,235,000 shares outstanding, as reported by Avadel Pharmaceuticals plc on its Form 10-Q dated September 30, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Avadel Pharmaceuticals plc’s 10-Q dated September 30, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At Avadel Pharmaceuticals plc's 2 shareholder meetings in the 2025-2026 proxy season (held July 29, 2025 and January 12, 2026), 229 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,762 separate fund positions. Their filings are grouped here into 18 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held January 12, 2026 — ORDINARY RESOLUTION TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, SPECIFIED COMPENSATORY… — Avadel Pharmaceuticals plc's filing reports the proposal as approved, with 86% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Avadel Pharmaceuticals plc's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on January 12, 2026.
Avadel Pharmaceuticals plc proxy season coverage: 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.